ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

ClinicalTrials.gov ID: NCT05599815

Public ClinicalTrials.gov record NCT05599815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Study identification

NCT ID
NCT05599815
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • ADX-629 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2022
Primary completion
Apr 30, 2023
Completion
Apr 30, 2023
Last update posted
Apr 16, 2024

2023

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Amicis Research Center - Northridge Northridge California 91324
University of Colorado Aurora Colorado 80045
South Florida Research Institute Lauderdale Lakes Florida 33309
Emory University - Pediatric Nephrology Atlanta Georgia 30322
ClinCept, LLC Bremen Georgia 30110
Northwest Louisiana Nephrology Shreveport Louisiana 71101
Nevada Kidney Disease Hypertension Center (NKDHC) Las Vegas Nevada 88901
East Carolina University - Nephrology Greenville North Carolina 27834
The Ohio State University (OSU) Wexner Medical Center Columbus Ohio 43004
University of Toledo Medical Center Toledo Ohio 43537
Southern Utah Kidney and Hypertension Center St. George Utah 84765

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05599815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2024 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05599815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →